Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Common-Size Balance Sheet: Assets 
Quarterly Data

Edwards Lifesciences Corp., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Cash and cash equivalents 10.15 18.47 17.13 16.28 16.35 15.06 14.06 10.91 18.17 19.89 13.04 12.97 13.41 21.17 21.57 21.06 14.37 11.48 9.89 17.14
Short-term investments 7.10 3.53 3.24 2.17 3.03 3.99 4.05 6.06 5.21 2.85 3.72 4.64 4.55 5.61 3.07 4.67 9.12 14.08 12.14 2.07
Accounts receivable, net of allowances 6.85 7.36 8.36 8.13 7.11 8.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other receivables 0.97 0.78 0.78 1.08 1.22 1.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts and other receivables, net of allowances (legacy) 0.00 0.00 0.00 0.00 0.00 0.00 8.84 9.63 9.23 9.55 10.94 10.57 10.09 8.90 9.15 7.67 8.11 8.65 9.94 10.67
Inventories 8.55 9.04 9.91 10.65 11.09 11.37 11.44 10.90 9.88 10.24 11.21 11.54 11.40 9.80 9.99 9.85 9.74 9.81 9.57 9.02
Prepaid expenses 1.00 0.94 0.90 1.07 1.04 1.01 0.89 1.08 0.91 0.96 1.00 1.01 1.02 0.88 1.23 1.34 1.06 0.96 1.05 1.11
Other current assets 2.79 2.96 3.04 3.18 2.88 2.52 2.59 2.69 2.59 2.42 2.34 2.59 2.48 2.52 2.41 2.04 2.05 1.77 1.85 2.21
Current assets 37.41% 43.08% 43.37% 42.55% 42.71% 43.82% 41.88% 41.27% 45.99% 45.92% 42.25% 43.31% 42.96% 48.88% 47.41% 46.64% 44.46% 46.76% 44.44% 42.22%
Long-term investments 21.57 15.71 13.24 11.12 11.08 8.81 9.25 9.67 9.02 6.47 7.41 8.30 9.51 8.04 8.27 9.13 9.95 10.34 10.73 10.86
Property, plant, and equipment, net 18.19 17.95 18.87 19.66 19.28 18.77 18.61 18.11 16.34 16.32 16.71 16.31 16.30 13.86 13.55 12.22 11.93 11.84 12.22 12.32
Operating lease right-of-use assets 1.08 1.04 1.10 1.23 1.30 1.32 1.32 1.24 1.23 1.23 1.28 1.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 13.74 14.34 15.29 16.23 16.21 17.20 18.18 19.19 18.00 19.39 21.06 20.17 20.89 18.84 19.67 19.65 19.78 17.86 18.78 19.77
Other intangible assets, net 3.81 3.99 4.27 4.58 4.58 4.89 5.19 5.51 5.19 6.39 6.92 6.24 6.45 7.85 8.20 8.25 8.22 7.56 7.95 8.41
Deferred income taxes 2.90 2.25 2.49 2.90 3.19 3.16 3.18 2.60 2.65 2.61 2.94 3.01 3.27 1.93 2.29 3.11 3.75 3.59 3.60 3.75
Other assets 1.30 1.64 1.37 1.74 1.65 2.03 2.39 2.39 1.57 1.68 1.44 1.38 0.63 0.59 0.61 0.99 1.91 2.05 2.27 2.67
Long-term assets 62.59% 56.92% 56.63% 57.45% 57.29% 56.18% 58.12% 58.73% 54.01% 54.08% 57.75% 56.69% 57.04% 51.12% 52.59% 53.36% 55.54% 53.24% 55.56% 57.78%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Edwards Lifesciences Corp. current assets as a percentage of total assets decreased from Q2 2021 to Q3 2021 and from Q3 2021 to Q4 2021.
Property, plant, and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Edwards Lifesciences Corp. property, plant, and equipment, net as a percentage of total assets decreased from Q2 2021 to Q3 2021 but then slightly increased from Q3 2021 to Q4 2021.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Edwards Lifesciences Corp. long-term assets as a percentage of total assets increased from Q2 2021 to Q3 2021 and from Q3 2021 to Q4 2021.